SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001714899-24-000098
Filing Date
2024-04-02
Accepted
2024-04-02 18:07:46
Documents
1
Period of Report
2024-04-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1712095651.html 4  
1 FORM 4 wk-form4_1712095651.xml 4 4713
  Complete submission text file 0001714899-24-000098.txt   6159
Mailing Address 863 MITTEN ROAD, SUITE 102 BURLINGAME CA 94010
Business Address
Krognes Steve E. (Reporting) CIK: 0001666236 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38311 | Film No.: 24816068

Mailing Address 161 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 161 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 (650) 866-8548
Denali Therapeutics Inc. (Issuer) CIK: 0001714899 (see all company filings)

IRS No.: 463872213 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)